Board of Directors
Sopharma AD informs that the Board of Directors of Sopharma AD authorized the Executive Director of the company to undertake negotiations for the sale of the shares of Extab Corporation owned by Sopharma AD.
Sopharma AD informs that the Board of Directors of Sopharma AD authorized the Executive Director of the company to undertake negotiations for the sale of the shares of Extab Corporation owned by Sopharma AD.
Sopharma AD informs that today Sopharma reached an agreement for the sale of 75% of the capital of Extab Corporation. After the transaction Sophama will remain a shareholder in the company with 5%.
SOPHARMA AD hereby informs that from 14 May 2015 up to and including 20 May 2015 the Company bought 3312 own shares representing 0.0025% of the share capital of the Company, at a total value of 10 274.19 BGN on the Bulgarian Stock Exchange, the average price per share was 3.10 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 167 132, representing 3.83% of the share capital of the Company.
SOPHARMA AD hereby informs that from 21 May 2015 up to and including 27 May 2015 the Company bought 2000 own shares representing 0.0015% of the share capital of the Company, at a total value of 6 130.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.07 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 169 132, representing 3.83% of the share capital of the Company.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 4 October 2012 up to and including 10 October 2012 the Company bought 1020 own shares representing 0.00077% of the share capital of the Company, to the total value of BGN 2432.6 on the Bulgarian Stock Exchange. The average price per share was BGN 2.38.
The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.
"Chcę powiedzieć, że nasz sukces jest wynikiem ciężkiej pracy wszystkich pracowników i chciałbym im podziękować" Ognian Donev, CEO
Pielęgnujemy długotrwałe relacje z naszymi pracownikami, oparte na zaufaniu i lojalności, głęboko zakorzenione w naszym przekonaniu znaczenie samorealizacji, aby poprawić osiągi firmowe.
Work-life balance
Globalizacja jest wyzwaniem w każdym aspekcie naszego życia. Dla globalnej społeczności inwestorów możliwość sprawdzenia prawa głosu bez konieczności sprawdzenia zawartości pliku Frequent Flyer jest oczywistą zaletą. Dla Sopharma AD wysiłek ten jest wkładem w doskonalenie pliku ładu korporacyjnego.
Jesteśmy przekonani, że partnerstwo na rzecz rozwoju jest sposobem, aby być odpowiedzialnymi partnerami korporacyjnymi oraz twórcami innowacyjnych procesów zgodnie z najwyższymi standardami moralnymi.
Znaleźliśmy potwierdzenie naszej firmowej filozofii w dziesięciu zasad Global Compact ONZ, jak również, że nasze strategia biznesowa jest zgodna z aktualnymi trendami rozwoju współczesnego świata. Stanowi to powód naszego zaangażowania w bułgarską sieci UN Global Compact.
Sopharma AD notifies that for May 2015 the Company recorded an increase of sales revenues of 3% compared to the same month of 2014, including 14% increase of domestic sales and 2% decrease of export sales.
For the five months of this year, revenues from sales decreased by 12% compared to the same period of 2014, including 16% increase of domestic sales and a 22% decrease of export sales.
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that in order to achieve synergies in the Sopharma Group, optimization of the management of products in the domestic market and higher efficiency of resources, the team responsible for the products produced by Sopharma AD and intended for the free market (OTC products) in being transferred to Sopharma Trading AD. The management of both companies believes that this is a logical step in improving the performance and quality of the work of the Group.